Skip to main content
Vaccine equity campaigners slam Pfizer’s ‘profiteering’ as company increases C-19 vaccine prices for NHS
Pfizer-BioNTech vaccine

VACCINE equity campaigners slammed Pfizer’s “profiteering” during a pandemic today after the company increased Covid-19 vaccine prices for the NHS. 

Britain will reportedly pay £1 billion for 35 million doses of Pfizer’s vaccine for “booster” jabs next year, with prices increasing a fifth from £18 to £22 a dose. 

Global Justice Now warned that by ordering millions of “overpriced” booster jabs, Britain is sending low and middle-income countries who are struggling to access vaccines to the back of the queue. 

The 95th Anniversary Appeal
Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
Similar stories
Selling us out: Keir Starmer signs a deal with Donald Trump
Features / 8 July 2026
8 July 2026

CLAUDIA WEBBE says the horrific price British patients will pay for this NHS deal is now clear — and there’s time to get out of it, if MPs will only force the issue

People fill jugs with water in Havana, Cuba, June 12, 2026
Global Healthcare / 18 June 2026
18 June 2026

The US blockade of Cuba raises risks of a new global pandemic, experts warn at Unison conference

COST CONTROL MODE: Health Secretary Wes Streeting during a visit to NHS National Operations Centre in London on July 25 2025
Features / 18 September 2025
18 September 2025

Politicians who continue to welcome contracts with US companies without considering the risks and consequences of total dependency in the years to come are undermining the raison d’etre of the NHS, argues Dr JOHN PUNTIS